The Oncology Institute, Inc. (NASDAQ:TOIIW) Short Interest Update

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totaling 5,294 shares, a decline of 50.8% from the April 30th total of 10,750 shares. Based on an average daily volume of 3,547 shares, the short-interest ratio is currently 1.5 days.

Oncology Institute Price Performance

NASDAQ:TOIIW remained flat at $0.05 during mid-day trading on Monday. The company had a trading volume of 111 shares, compared to its average volume of 15,481. The company has a 50-day moving average of $0.05 and a 200 day moving average of $0.10. Oncology Institute has a 12-month low of $0.03 and a 12-month high of $0.27.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies.